Southern First Bancshares, Inc. operates as the bank holding company for Southern First Bank that provides commercial, consumer, and mortgage loans to the general public in South Carolina, North Carolina, and Georgia. The company accepts various deposit products that include checking accounts, commercial checking accounts, and savings accounts, as well as other time deposits, including daily money market accounts and long-term certificates of deposit. Its loan portfolio comprises commercial real estate loans; construction real estate loans; commercial business loans for various lines of businesses, such as the manufacturing, service industry, and professional service areas; consumer real estate and home equity loans; and other consumer loans, including secured and unsecured installment loans and revolving lines of credit. In addition, the company offers other bank services, such as internet banking, cash management, safe deposit boxes, direct deposit, automatic drafts, bill payment, and mobile banking services. The company was incorporated in 1999 and is headquartered in Greenville, South Carolina.…
Southern First Bancshares (SFST) Stock Climbs On Q3 Earnings Strength
Southern First Bancshares (NASDAQ: SFST) is listed on Nasdaq, where its shares trade in USD. It belongs to the Banks - Regional industry, part of the Financial Services sector, and reports about 315 employees.
The shares were at 56.90 USD on 20 November 2026, up 28.2% over 52 weeks. Its 52-week range is 44.00 USD to 65.09 USD: the price is 12.6% below the high and 29.3% above the low.
At a market capitalisation of 540.04M USD, it trades at 11.7 times trailing earnings and 9.4 times forward earnings. The median trailing P/E of its 20 largest Banks - Regional peers is 10.3, a premium of 13% for SFST.
Southern First Bancshares reports return on equity of 8.2%, an operating margin of 44.0% and revenue up 19.3% year over year.
It holds more cash than debt, a net cash position of 119.71M USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 2 analysts cover the stock; their mean price target of 68.75 USD is 20.8% above the current price. The next earnings report is expected on 21 January 2027.